These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Buruli ulcer disease in Republic of the Congo. Marion E; Obvala D; Babonneau J; Kempf M; Asiedu KB; Marsollier L Emerg Infect Dis; 2014 Jun; 20(6):1070-2. PubMed ID: 24857328 [No Abstract] [Full Text] [Related]
3. Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease. Phillips RO; Sarfo FS; Abass MK; Abotsi J; Wilson T; Forson M; Amoako YA; Thompson W; Asiedu K; Wansbrough-Jones M Antimicrob Agents Chemother; 2014; 58(2):1161-6. PubMed ID: 24323473 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Etuaful S; Carbonnelle B; Grosset J; Lucas S; Horsfield C; Phillips R; Evans M; Ofori-Adjei D; Klustse E; Owusu-Boateng J; Amedofu GK; Awuah P; Ampadu E; Amofah G; Asiedu K; Wansbrough-Jones M Antimicrob Agents Chemother; 2005 Aug; 49(8):3182-6. PubMed ID: 16048922 [TBL] [Abstract][Full Text] [Related]
12. High-Dose Rifamycins Enable Shorter Oral Treatment in a Murine Model of Mycobacterium ulcerans Disease. Omansen TF; Almeida D; Converse PJ; Li SY; Lee J; Stienstra Y; van der Werf T; Grosset JH; Nuermberger EL Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455239 [TBL] [Abstract][Full Text] [Related]
13. Buruli ulcer in West Africa: strategies for early detection and treatment in the antibiotic era. Webb BJ; Hauck FR; Houp E; Portaels F East Afr J Public Health; 2009 Aug; 6(2):144-7. PubMed ID: 20000019 [TBL] [Abstract][Full Text] [Related]
15. Confirmed Case of Buruli Ulcer, Senegal, 2018. Turner GA; Seck A; Dieng A; Diadie S; Ndiaye B; van Imeerzeel TD; Diallo M; Kempf M; Bercion R; Boye CS Emerg Infect Dis; 2019 Mar; 25(3):600-601. PubMed ID: 30789331 [TBL] [Abstract][Full Text] [Related]
16. Chronic cutaneous mycobacterial ulcers due to Mycobacterium ulcerans (Buruli ulcer): the first indigenous case report from Jordan and a literature review. Al Ramahi JW; Annab H; Al Karmi M; Kirresh B; Wreikat M; Batarseh R; Yacoub M; Kaderi M Int J Infect Dis; 2017 May; 58():77-81. PubMed ID: 28344056 [TBL] [Abstract][Full Text] [Related]
17. Child case of Buruli ulcer successfully treated through a school-based skin survey project in Côte d'Ivoire. Yotsu RR; Murase C; N'guessan K; Yao A; Kouadio K; N'Golo DC; N'Guetta A; Akiyama M; Constance K; Vagamon B J Dermatol; 2020 Feb; 47(2):e64-e65. PubMed ID: 31729074 [No Abstract] [Full Text] [Related]
18. Epidemiology and management of Buruli ulcer. Huang GK; Johnson PD Expert Rev Anti Infect Ther; 2014 Jul; 12(7):855-65. PubMed ID: 24918117 [TBL] [Abstract][Full Text] [Related]
19. Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease. Sarfo FS; Converse PJ; Almeida DV; Zhang J; Robinson C; Wansbrough-Jones M; Grosset JH PLoS Negl Trop Dis; 2013; 7(3):e2101. PubMed ID: 23516649 [TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model. Ruf MT; Schütte D; Chauffour A; Jarlier V; Ji B; Pluschke G Antimicrob Agents Chemother; 2012 Feb; 56(2):687-96. PubMed ID: 22143518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]